Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.46)
# 870
Out of 4,862 analysts
140
Total ratings
50%
Success rate
3.2%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Outperform | $600 → $400 | $313.53 | +27.58% | 16 | May 14, 2025 | |
| HUM Humana | Maintains: Outperform | $300 → $310 | $235.26 | +31.77% | 13 | May 1, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $317.40 | +18.15% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $6.86 | +74.93% | 11 | Jan 24, 2025 | |
| CNC Centene | Maintains: Outperform | $95 → $85 | $55.22 | +53.93% | 17 | Dec 13, 2024 | |
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $27.61 | +34.01% | 6 | Nov 8, 2024 | |
| HCA HCA Healthcare | Maintains: Outperform | $390 → $400 | $371.18 | +7.76% | 11 | Oct 28, 2024 | |
| ENSG The Ensign Group | Maintains: Outperform | $165 → $168 | $151.24 | +11.08% | 8 | Oct 25, 2024 | |
| ADUS Addus HomeCare | Maintains: Outperform | $140 → $145 | $113.15 | +28.15% | 10 | Sep 23, 2024 | |
| PACS PACS Group | Maintains: Outperform | $32 → $40 | $10.32 | +287.60% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $3.20 | +56.25% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $9.78 | - | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $650 | $551.15 | +17.94% | 12 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $145 | $97.16 | +49.24% | 10 | Oct 28, 2022 |
UnitedHealth Group
May 14, 2025
Maintains: Outperform
Price Target: $600 → $400
Current: $313.53
Upside: +27.58%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300 → $310
Current: $235.26
Upside: +31.77%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $317.40
Upside: +18.15%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $6.86
Upside: +74.93%
Centene
Dec 13, 2024
Maintains: Outperform
Price Target: $95 → $85
Current: $55.22
Upside: +53.93%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $27.61
Upside: +34.01%
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390 → $400
Current: $371.18
Upside: +7.76%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $151.24
Upside: +11.08%
Addus HomeCare
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $113.15
Upside: +28.15%
PACS Group
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $10.32
Upside: +287.60%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $3.20
Upside: +56.25%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $9.78
Upside: -
Feb 29, 2024
Maintains: Outperform
Price Target: $625 → $650
Current: $551.15
Upside: +17.94%
Oct 28, 2022
Maintains: Outperform
Price Target: $175 → $145
Current: $97.16
Upside: +49.24%